| Name | Title | Contact Details |
|---|---|---|
Bryan Monroe |
Senior Vice President, Research & Development, DJO Surgical | Profile |
Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.
Parkland is a diverse community of 30,000, and the City provides a variety of services for these citizens. Learn more about what Parkland has to offer you and your family! Parkland is a tranquil city nestled in a serene, wooded environment in Northwest...
LearnWright is a Potomac, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Certara is a leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes. Certara`s solutions, which span the drug development and patient care lifecycle, help increase the probability of regulatory and commercial success by using the most scientifically advanced modeling and simulation technologies and regulatory strategies. Its clients include hundreds of global biopharmaceutical companies, leading academic institutions and key regulatory agencies.
As the industry`s largest care access platform Kyruus Health enables our partners to efficiently guide and match people to the care that`s right for them. We create connections across the entire healthcare ecosystem so that every stakeholder can access and harness the most accurate, comprehensive, and contextually relevant information. By enabling informed decisions and confident action, we support healthier outcomes, reduce friction in healthcare, and grant more time back in everyone`s day. At the heart of care access, we connect people to healthcare in a whole new way.